Fully extensible peptide active pharmaceutical ingredients (apis) from early clinical to commercial products because the different physiological parts of peptides make them appropriate support masters changes.There is a broad array of physiological activities influenced by bioactive peptides, and these biological activities are controlled by the type, number, progression, and nature of the amino acids shown in the peptides.
This report contains market size and forecasts of Peptide APIs in global, including the following market information:
Global Peptide APIs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Peptide APIs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Peptide APIs companies in 2021 (%)
The global Peptide APIs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liquid Phase Peptide Synthesis (LPPS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peptide APIs include CordenPharma, PolyPeptide, Bachem, AmbioPharm, Pepscan, BCN Peptides and Senn Chemicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide APIs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide APIs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Peptide APIs Market Segment Percentages, by Type, 2021 (%)
Liquid Phase Peptide Synthesis (LPPS)
Solid Phase Peptide Synthesis (SPPS)
Global Peptide APIs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Peptide APIs Market Segment Percentages, by Application, 2021 (%)
Cancer
Diabetes
Obesity
Fertility
Other
Global Peptide APIs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Peptide APIs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide APIs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Peptide APIs revenues share in global market, 2021 (%)
Key companies Peptide APIs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Peptide APIs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CordenPharma
PolyPeptide
Bachem
AmbioPharm
Pepscan
BCN Peptides
Senn Chemicals